C

Core Healthcare Group | Cerritos, CA

Research site
(Unclaimed)
Location
19123 Bloomfield Avenue, Cerritos, California, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 24
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of m...

Enrolling
Migraine
Drug: Lasmiditan

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks an...

Enrolling
Migraine
Drug: Placebo
Drug: Lasmiditan

This is phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menst...

Active, not recruiting
Uterine Fibroids
Heavy Menstrual Bleeding
Other: E2/NETA Placebo
Drug: E2/NETA

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared wi...

Active, not recruiting
Osteoarthritis, Knee
Drug: Pentosan Polysulfate Sodium once weekly
Drug: Pentosan Polysulfate Sodium Fixed Dose

Trial conditions

Leiomyoma (4 trials)
Myofibroma (4 trials)
Osteoarthritis (4 trials)
Hemorrhage (3 trials)
Knee Osteoarthritis (3 trials)
Menorrhagia (3 trials)
Migraine Disorders (3 trials)
Chronic Pain (2 trials)
Overactive Urinary Bladd... (2 trials)
Sleep Initiation and Mai... (2 trials)

And 18 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems